Adam R. Craig, President and CEO at CTI BIOPHARMA CORP (CTIC), sold 90,446 shares at $6.01 ($543K) on 2022-06-03, disclosed to the SEC on 2022-06-03.
Open-market sale of $543k CTIC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.00 | 27,000 | $162K | 29.8% |
| 2 | $6.00 | 27,000 | $162K | 29.8% |
| 3 | $6.01 | 18,223 | $110K | 20.2% |
| 4 | $6.01 | 18,223 | $110K | 20.2% |
| Total | $6.00 avg | 90,446 | $543K | 100% |
| Filing → |
| CTIC | SELL | 2023-01-26 | $512K | — | Filing → |
| CTIC | SELL | 2023-01-03 | $1.2M | — | Filing → |
| CTIC | SELL | 2022-11-14 | $1.6M | — | Filing → |